TotalMarketCap

Can-Fite BioPharma

CANFNYSE IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$4.850 M

$1.60 -4.13%

Close of 6 Nov 2026

As of 6 Nov 2026, Can-Fite BioPharma (CANF) has a market capitalization of $4.85M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$405.0K

#3520 by revenue

Earnings

-$9.83M

Loss-making

Shares outstanding

2,618,425

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #452ImunonIMNN$4.86M
  2. #453Addex TherapeuticsADXN$4.86M
  3. #454Can-Fite BioPharmaCANF$4.85M
  4. #455Skye BioscienceSKYE$4.65M
  5. #456Xenetic BiosciencesXBIO$4.43M

What if Can-Fite BioPharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$9,314,345

Per share 5,821,466× higher

Bitcoin $1.53T

$503,983.00

Per share 314,989× higher

Apple $5.02T

$1,654,529

Per share 1,034,081× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Can-Fite BioPharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.